The Impact of Generic Medicines on the European Pharmaceutical Market: The Example of Poland

• Autorzy: Julia Matsuieva
• Języki publikacji: EN

Abstrakty

EN

In this paper has been done a review of the existing situation on European pharmaceutical market. It was found that the Polish pharmaceutical market is quite different from other countries of the European Union. The share of generic medicines in Poland is the highest in the European Union. Quantitatively about 85% of the pharmaceutical market is composed of generic drugs. The social role of generics is expressed in their accessibility, affordable price, diversity and security for the most vulnerable part of the population - people with various health problems. It is impossible to overestimate the importance of generic medicines in both saving of the state's budgets and the rational use of public finances. (original abstract)

Słowa kluczowe

EN

Pharmaceutical market; Medications; Price competition; International comparisons

PL

Rynek farmaceutyczny; Leki; Konkurencja cenowa; Porównania międzynarodowe

• Czasopismo: Ekonomia - Wroclaw Economic Review
• Rocznik: 2017
• Numer: tom 23, nr 4
• Strony: 251--260

Twórcy

autor

Julia Matsuieva

• University of Wroclaw

Bibliografia

• Januszewski R., Bondary K. (2007), Pharmaceutical Pricing and Reimbursement Information Profile Poland, Vienna.
• Keenum A.J. (2012), Generic medications for you, but brand-name medications for me, "Research in Social and Administrative Pharmacy" 8 (6), pp. 574-578.
• Kvesic D.Z. (2008), Product lifecycle management: Marketing strategies for the pharmaceutical industry, "Journal of Medical Marketing" 8 (4), pp. 293-301.
• Light D.W., Lexchin J. (2012), Pharmaceutical research and development: What do we get for all that money? BMJ (Clinical Research Ed.) 7.08., pp. 345-348, https://www.bmj.com/content/345/bmj.e4348 (access: 7.06.2017).
• Rankin P.J., Bell K.G., Wilson T., The Pharmaceutical Pricing Compendium, Boston, chapter 2. Global pricing strategies for Pharmaceutical Product launches, pp. 1-7.
• Simoens S. (2013), Sustainable Provision of Generic Medicines in Europe. Report for the European Generic Medicines Association, June.
• Simoens S., De Coster S. (2006), Sustaining generic medicine markets in Europe, "Journal of Generic Medicines", Vol. 3, Is. 4, pp. 257-268.
• Szalonka K. (2011), Opieka farmaceutyczna w ochronie zdrowia Polaków, Warszawa.

Identyfikatory

DOI

10.19195/2084-4093.23.4.20